Truth: youll also lose less weight
In a 2025 case study published in Nature Medicine, brain recordings from one patient taking tirzepatide (the drug in Mounjaro) showed that the brain activity linked to her food preoccupation went quiet when she reached the full dose
All in all, its a great option for people who dont need all the bells and whistles of a more-expensive option but still want access to reliable data
Over the two-year study period, patients receiving GLP-1based therapy experienced: Importantly, the study authors did not observe an increased risk for key diabetes-related complications, including diabetic ketoacidosis and hypoglycemia
Shelf life and expiration Compounded medications typically have shorter shelf lives than brand-name versions
Take the first step towards a healthier, more vibrant life by exploring the benefits of GLP-1 Peptide therapy with our compassionate and skilled team